NCT06379243

Brief Summary

In this project, IDEAL-IQ technology and PDFF and R2\* image-based imaging methods are used to analyze the intrinsic relationship between preoperative vertebral bone marrow fat content, magnetic susceptibility properties of bone tissue and bone strength (bone volume and bone mass), to explore the mechanism of vertebral re-fracture after PVP / PKP, and to explore the imaging markers for the risk of postoperative vertebral re-fracture after PVP / PKP. To construct a precise and individualized risk assessment model of vertebral re-fracture after PVP/ PKP by combining clinical risk factors, preoperative quantitative MRI parameters (PDFF, R2\*) and imaging characteristics, so as to achieve the goal of objectively and accurately evaluating the risk of vertebral re-fracture at the early stage of the postoperative period (1 year).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
560

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Dec 2023Dec 2027

Study Start

First participant enrolled

December 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 23, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

April 23, 2024

Status Verified

April 1, 2024

Enrollment Period

3.1 years

First QC Date

April 17, 2024

Last Update Submit

April 21, 2024

Conditions

Keywords

osteoporosisspinal vertebral fracturesPVP / PKP treatment

Outcome Measures

Primary Outcomes (1)

  • Non-operative vertebral re-fracture within 1 year after PVP / PKP

    Non-operative vertebral re-fracture within 1 year after PVP / PKP, confirmed by follow-up spinal MRI

    1 year

Secondary Outcomes (2)

  • Visual Analog Score (VAS) at 1 year after PVP/ PKP

    1 year

  • Oswestry Dysfunction Index (ODI) at 1 year after PVP/PKP

    1 year

Study Arms (1)

non-operative vertebra refracture

EXPERIMENTAL

observe non-operative vertebra refracture after PVP/PKP surgery.

Procedure: PVP/PKP

Interventions

PVP/PKPPROCEDURE

PVP or PKP surgery in patients with osteoporotic vertebral compression fractures

non-operative vertebra refracture

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with osteoporotic vertebral fractures of the thoracic and lumbar level with reference to the 2022 edition of the Osteoporotic Fractures Guidelines (2022 edition);
  • The presence of bone marrow edema or hemorrhage (acute fracture) in the fractured vertebrae is clearly defined by MR examination, and the responsible vertebrae is treated with PVP / PKP;
  • Number of fractured vertebrae: 1-3 vertebral compression fractures (including old fractures).

You may not qualify if:

  • History of severe scoliosis, vertebroplasty, or internal spinal fixation;
  • Presence of spinal infection and malignant neoplastic disease;
  • Presence of mental disease, cognitive impairment, or critical illness (e.g., severe cardiac or cerebrovascular disease).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Seventh Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

RECRUITING

MeSH Terms

Conditions

Osteoporotic FracturesFractures, CompressionOsteoporosis

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • qingyu liu

    The Seventh Affiliated Hospital of Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
chief physician

Study Record Dates

First Submitted

April 17, 2024

First Posted

April 23, 2024

Study Start

December 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

April 23, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations